SCOPUS 정보 검색 플랫폼

Volumn 32, Issue 13, 1996, Pages 2366-2368

A phase I/II trial of epirubicin and high dose tamoxifen as a potential modulator of multidrug resistance in advanced hepatocellular carcinoma [2]

(7) Raderer, M b Pidlich, J a Muller C a Pfeffel, F a Kornek, G V b Hejna, M b Scheithauer, W b

a MEDICAL UNIVERSITY OF VIENNA (Austria)

b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; TAMOXIFEN;

BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; GRANULOCYTOPENIA; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LEUKOPENIA; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TAMOXIFEN;

EID: 0030461993 PISSN: 09598049 EISSN: None Source Type: Journal
DOI: 10.1016/S0959-8049(96)00280-8 Document Type: Letter

Times cited : (5)

References (8)

1
- 0000629711
- Cancer of the hepatobiliary system
- DeVita V, Hellman S, Rosenberg SA, eds. Philadelphia, Lippincott
- 1. Wanebo HJ, Falkson G, Order SE. Cancer of the hepatobiliary system. In DeVita V, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 4th edn Philadelphia, Lippincott, 1989, 836-874.
- (1989) Cancer: Principles and Practice of Oncology, 4th Edn , pp. 836-874
- Wanebo, H.J.¹ Falkson, G.² Order, S.E.³

2
- 0028332826
- Treatment of hepatocellular carcinoma: Too many options?
- 2. Venook AP. Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 1994, 12, 1323-1334.
- (1994) J Clin Oncol , vol.12 , pp. 1323-1334
- Venook, A.P.¹

3
- 0026524781
- Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma
- 3. Huang C, Wu M, Xu G, et al. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma. J Natl Cancer Inst 1992, 84, 262-264.
- (1992) J Natl Cancer Inst , vol.84 , pp. 262-264
- Huang, C.¹ Wu, M.² Xu, G.³

4
- 0028334832
- MDR1 gene expression: Its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines
- 4. Park JG., Lee SK, Hong IG, et al. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. J Natl Cancer Inst 1994, 86, 700-705.
- (1994) J Natl Cancer Inst , vol.86 , pp. 700-705
- Park, J.G.¹ Lee, S.K.² Hong, I.G.³

5
- 0021162802
- Reversal of acquired resistance to doxorubicin in p833 murine leukemia cells by tamoxifen and other triparanol analogues
- 5. Ramu A, Glaubiger D, Fuks F. Reversal of acquired resistance to doxorubicin in P833 murine leukemia cells by tamoxifen and other triparanol analogues. Cancer Res 1984, 44, 4392-4395.
- (1984) Cancer Res , vol.44 , pp. 4392-4395
- Ramu, A.¹ Glaubiger, D.² Fuks, F.³

6
- 0026445750
- High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: Phase I trial in combination with vinblastine
- 6. Trump DL, Smith DC, Ellis PG, et al. High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine. J Natl Cancer Inst 1992, 84, 1811-1816.
- (1992) J Natl Cancer Inst , vol.84 , pp. 1811-1816
- Trump, D.L.¹ Smith, D.C.² Ellis, P.G.³

7
- 0026608377
- Prospective controlled trial with antioestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma
- 7. Farinati F, De Maria A, Fornasiero A, et al. Prospective controlled trial with antioestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma. Digest Dis Sci 1992, 37, 659-662.
- (1992) Digest Dis Sci , vol.37 , pp. 659-662
- Farinati, F.¹ De Maria, A.² Fornasiero, A.³

8
- 0028980686
- Resistance to cytotoxic therapy: A speculative overview
- 8. Preisler HD. Resistance to cytotoxic therapy: a speculative overview. Ann Oncol 1995, 6, 651-657.
- (1995) Ann Oncol , vol.6 , pp. 651-657
- Preisler, H.D.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.